BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 24, 2018
Product R&D

Bias-less bispecifics

How Merus’ HER2/3 bispecific could succeed in breast cancer where HER3 mAbs failed
BioCentury | Jun 16, 2014
Clinical News

MM-121: Additional Phase II data

BioCentury | Jun 16, 2014
Clinical News

MM-121: Additional Phase II data

BioCentury | Jun 16, 2014
Clinical News

MM-121: Additional Phase II data

BioCentury | Dec 6, 1993
Company News

Bristol-Myers Squibb other research news

Items per page:
1 - 5 of 5